Most importantly, Infraredx is committed to maintaining the highest standards for its products and technologies – from research and development, to sales and marketing, to product support.
Robert McNeil, Managing Director at Sanderling Ventures discusses the importance of lipid core plaque (LCP) detection using the TVC Imaging System. He emphasizes the need to detect LCPs with the intention of reducing post PCI complications and associated cost.
The LRP study is a prospective study to demonstrate the potential for the TVC Imaging System to assess cardiovascular risk, enhance clinical decision-making, and improve patient outcomes.
The CANARY clinical study is a randomized pilot trial of the use of a distal protection device to prevent peri-procedural MI during dilation of coronary stenoses caused by plaques with large lipid cores. Visit the ClinicalTrials.gov website for more information.
The COLOR Registry underscores an Infraredx goal of improving the understanding of coronary artery disease and the effect of lipid core plaques.